140 related articles for article (PubMed ID: 34708231)
1. [The role of SIRT6 in nonalcoholic steatohepatitis].
Jing XD; Tang Q; He JH
Sheng Li Xue Bao; 2021 Oct; 73(5):745-754. PubMed ID: 34708231
[TBL] [Abstract][Full Text] [Related]
2. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation.
Hou T; Tian Y; Cao Z; Zhang J; Feng T; Tao W; Sun H; Wen H; Lu X; Zhu Q; Li M; Lu X; Liu B; Zhao Y; Yang Y; Zhu WG
Mol Cell; 2022 Nov; 82(21):4099-4115.e9. PubMed ID: 36208627
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
Ka SO; Bang IH; Bae EJ; Park BH
FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
[TBL] [Abstract][Full Text] [Related]
5. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.
Zhu Y; Hu S; Pan X; Gopoju R; Cassim Bawa FN; Yin L; Xu Y; Zhang Y
Cells; 2023 Aug; 12(15):. PubMed ID: 37566087
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 6-A Key Regulator of Hepatic Lipid Metabolism and Liver Health.
Dong XC
Cells; 2023 Feb; 12(4):. PubMed ID: 36831330
[TBL] [Abstract][Full Text] [Related]
8. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
9. Human centenarian-associated SIRT6 mutants modulate hepatocyte metabolism and collagen deposition in multilineage hepatic 3D spheroids.
Frohlich J; Raffaele M; Skalova H; Leire E; Pata I; Pata P; Gorbunova V; Vinciguerra M
Geroscience; 2023 Apr; 45(2):1177-1196. PubMed ID: 36534275
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease.
Pan Z; Guo J; Tang K; Chen Y; Gong X; Chen Y; Zhong Y; Xiao X; Duan S; Cui T; Wu X; Zhong Y; Yang X; Shen C; Gao Y
J Agric Food Chem; 2022 Nov; 70(44):14220-14234. PubMed ID: 36300841
[TBL] [Abstract][Full Text] [Related]
12. GB1a Activates SIRT6 to Regulate Lipid Metabolism in Mouse Primary Hepatocytes.
Sun Y; Zheng C; Li T; He X; Yang F; Guo W; Song J; Gao Y; Deng C; Huang X
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298491
[TBL] [Abstract][Full Text] [Related]
13. SIRT6: therapeutic target for nonalcoholic fatty liver disease.
Zang M; Gao B
Trends Endocrinol Metab; 2022 Dec; 33(12):801-803. PubMed ID: 36328906
[TBL] [Abstract][Full Text] [Related]
14. SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK.
Cui X; Yao L; Yang X; Gao Y; Fang F; Zhang J; Wang Q; Chang Y
Am J Physiol Endocrinol Metab; 2017 Oct; 313(4):E493-E505. PubMed ID: 28765271
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
Greene MW; Burrington CM; Lynch DT; Davenport SK; Johnson AK; Horsman MJ; Chowdhry S; Zhang J; Sparks JD; Tirrell PC
PLoS One; 2014; 9(1):e85848. PubMed ID: 24454937
[TBL] [Abstract][Full Text] [Related]
16. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
17. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
[TBL] [Abstract][Full Text] [Related]
18. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
19. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis.
Bloomer SA; Olivier AK; Bergmann OM; Mathahs MM; Broadhurst KA; Hicsasmaz H; Brown KE
Cell Biochem Funct; 2016 Dec; 34(8):628-639. PubMed ID: 27935134
[TBL] [Abstract][Full Text] [Related]
20. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
